Literature DB >> 18434615

Strategies to inhibit cyst formation in ADPKD.

James P Calvet1.   

Abstract

The many hundreds of cysts that grow and expand and ultimately overwhelm and destroy polycystic kidneys arise from the slow but unrelenting proliferation of tubular epithelial cells, eventually giving rise to very large, thin-walled, fluid-filled structures. The growth of these cystic bodies requires two processes: Cell proliferation and fluid secretion. Cyst epithelial cells seem to have a unique phenotype that could offer opportunities for therapeutic intervention. Current evidence has demonstrated that cAMP drives both abnormal cell proliferation, by stimulating the Ras/mitogen-activated protein kinase (MAPK) pathway, and cyst-filling fluid secretion, by activating the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel. Both of these cAMP-mediated processes should be considered in the design of strategies targeted to slow cyst growth and enlargement in autosomal dominant polycystic kidney disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18434615     DOI: 10.2215/CJN.05651207

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  23 in total

1.  Renal function and healthcare costs in patients with polycystic kidney disease.

Authors:  Krista L Lentine; Huiling Xiao; Gerardo Machnicki; Adrian Gheorghian; Mark A Schnitzler
Journal:  Clin J Am Soc Nephrol       Date:  2010-06-10       Impact factor: 8.237

Review 2.  Molecular pathways and therapies in autosomal-dominant polycystic kidney disease.

Authors:  Takamitsu Saigusa; P Darwin Bell
Journal:  Physiology (Bethesda)       Date:  2015-05

3.  Polycystin-2 and phosphodiesterase 4C are components of a ciliary A-kinase anchoring protein complex that is disrupted in cystic kidney diseases.

Authors:  Yun-Hee Choi; Akira Suzuki; Sachin Hajarnis; Zhendong Ma; Hannah C Chapin; Michael J Caplan; Marco Pontoglio; Stefan Somlo; Peter Igarashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

4.  Loss of activator of G-protein signaling 3 impairs renal tubular regeneration following acute kidney injury in rodents.

Authors:  Kevin R Regner; Kandai Nozu; Stephen M Lanier; Joe B Blumer; Ellis D Avner; William E Sweeney; Frank Park
Journal:  FASEB J       Date:  2011-02-22       Impact factor: 5.191

Review 5.  Developmental signaling: does it bridge the gap between cilia dysfunction and renal cystogenesis?

Authors:  Pamela V Tran; Madhulika Sharma; Xiaogang Li; James P Calvet
Journal:  Birth Defects Res C Embryo Today       Date:  2014-05-26

6.  Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease.

Authors:  Guangfu Jia; Michelle Kwon; Huan Ling Liang; Jordan Mortensen; Vani Nilakantan; William E Sweeney; Frank Park
Journal:  Pediatr Nephrol       Date:  2010-03-13       Impact factor: 3.714

Review 7.  The role of the cilium in normal and abnormal cell cycles: emphasis on renal cystic pathologies.

Authors:  Junmin Pan; Tamina Seeger-Nukpezah; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2012-07-11       Impact factor: 9.261

Review 8.  New treatments for autosomal dominant polycystic kidney disease.

Authors:  Ming-Yang Chang; Albert C M Ong
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

9.  Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models.

Authors:  Hong Zhou; Jinsheng Gao; Li Zhou; Xin Li; Weidong Li; Xuejun Li; Yin Xia; Baoxue Yang
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-15

10.  Kidney transplant patient with immunoglobulin A nephropathy subsequently diagnosed as concurrent autosomal dominant polycystic kidney disease during 17-year follow-up.

Authors:  Joichi Usui; Hirayasu Kai; Shuzo Kaneko; Mayumi Takahashi-Kobayashi; Masahiro Hagiwara; Kazuhiro Takahashi; Tatsuya Oda; Kunihiro Yamagata
Journal:  CEN Case Rep       Date:  2019-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.